Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Investigational drugs may expand medical treatment of Cushing’s syndrome
-
- Presidential directive addresses drug shortages, but more action needed
- Financial worries leave doctors feeling blue, wearing blue jeans Richard O. Dolinar, MD
- ‘Weed’ out hyperthyroidism Ronald Tamler, MD, PhD, MBA
- SATURN and AIM-HIGH: ‘Back down to planet Earth’
- Continuous glucose monitoring system receives FDA approval
- Fenofibric acid may not lower risk for MI, stroke
- Incidental adrenal mass found on CT scan Gayatri Kuraganti, MD; Stephanie L. Lee, MD, PhD, ECNU
- Oral steroids linked to severe vitamin D deficiency in nationwide study
-
- Temozolomide well tolerated, effective in poorly differentiated endocrine carcinoma
- ATLAS ACS: Adding rivaroxaban to antiplatelet therapy reduced death rates in ACS
- Cardioprotective effects of diabetes drugs examined
- Enlarged cervical lymph nodes may signal thyroid cancer
- Glitazone pretreatment boosted I-131 uptake
- Management of medullary thyroid cancer remains challenging
- Public divided about insurance coverage for obese adolescents
- Role of HDL in predicting, preventing CVD questionable
-
- Telephone coaching as effective for weight loss as in-person counseling
- Universal screening for thyroid disease in pregnancy most cost-effective option